ArticleFoods (Basel, Switzerland)2026
Plant-Based Functional Formulae Mitigate Western Diet-Induced MASLD by Modulating Hepatic Oxidative Stress, Inflammation as Well as Nrf-2/HO-1 and NF-κB Gene Expression.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psyllium has long been used to improve satiety and control weight. Leek and dill leaves are abundant in bioactive substances that have been confirmed to have anti-inflammatory and antioxidant properties. Our goal was to assess the hepatoprotective effects of two formulae (dill and psyllium or leek and psyllium) against oxidative stress and inflammatory markers in a metabolic dysfunction-associated steatotic liver disease (MASLD) rat model. Twenty four rats were used in this study. Rats were given a high-fat, high-sucrose diet (HF/HS), a Western diet, to create a MASLD model. The two formulae showed lower levels of serum alanine transaminase and aspartate transaminase, as well as a preventive effect against obesity, as shown by lower levels of leptin (with changes of 60.57 and 67.14%, respectively) and body weight gain (with changes of 25.57 and 29.04%, respectively). The two formulae resulted in a reduction in blood glucose, insulin, cholesterol, triglycerides, oxidative markers, and inflammatory markers upon feeding on the HF/HS diet. The histological evaluation in rats treated with the two formulae revealed reduced hepatic vacuolization and lobular inflammation. The two formulations reduced the mRNA expression of nuclear factor-kappa B (NF-κB) while increasing the mRNA expression of nuclear erythroid 2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1). The results indicated the potential efficacy of the two prepared formulations in alleviating and preventing MASLD in the rat model evaluated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.